Phase II study: Radiotherapy dose increase to hypoxic NSCLC lesions
Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET) radiotracer that is widely used to diagnose hypoxia (insufficient oxygen supply to tissue), and non-small cell lung cancer (NSCLC) patients ...
Jul 10, 2017
0
0